AL
TEVA icon

Agran Libbie’s Teva Pharmaceuticals TEVA Stock Holding History

Agran Libbie’s Portfolio TEVA Stock Details TEVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q1 		$5.22M Sell
162,540
-7,765
-5% -$265K 1.23% 34
2016
Q4 		$6.17M Sell
170,305
-9,415
-5% -$376K 1.5% 30
2016
Q3 		$8.27M Sell
179,720
-4,375
-2% -$228K 2.36% 14
2016
Q2 		$9.25M Sell
184,095
-4,486
-2% -$239K 2.31% 9
2016
Q1 		$10.1M Sell
188,581
-4,800
-2% -$282K 2.58% 6
2015
Q4 		$12.7M Sell
193,381
-1,875
-1% -$116K 3.34% 2
2015
Q3 		$11M Sell
195,256
-4,275
-2% -$277K 3.08% 3
2015
Q2 		$11.8M Sell
199,531
-5,660
-3% -$349K 3.06% 3
2015
Q1 		$12.8M Sell
205,191
-2,050
-1% -$119K 3.04% 3
2014
Q4 		$11.9M Sell
207,241
-7,005
-3% -$390K 2.84% 4
2014
Q3 		$11.5M Sell
214,246
-5,142
-2% -$272K 2.82% 5
2014
Q2 		$11.5M Sell
219,388
-2,500
-1% -$128K 2.94% 5
2014
Q1 		$11.7M Sell
221,888
-11,985
-5% -$554K 3.16% 4
2013
Q4 		$9.37M Sell
233,873
-6,755
-3% -$266K 2.47% 9
2013
Q3 		$9.09M Sell
240,628
-5,104
-2% -$199K 2.64% 7
2013
Q2 		$9.63M Buy
+245,732
New +$9.57M 2.79% 6

Other funds holding TEVA

Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Barrow, Hanley, Mewhinney & Strauss
Barrow, Hanley, Mewhinney & Strauss Dallas, Texas $30.5B AUM 29.95% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
HCM
Highfields Capital Management Boston, Massachusetts $68.3M AUM 21.64% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
NC
Northern Cross Boston, Massachusetts $279M AUM 1.98% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Agran Libbie's TEVA Position: Q1 2017 in Review

Agran Libbie reduced its Teva Pharmaceuticals (TEVA) stake by 4.6% in Q1 2017, selling an estimated $265K and leaving 162,540 shares worth $5.22M. The position accounts for 1.23% of the portfolio, ranked #34.

Agran Libbie first reported a position in TEVA in Q2 2013 and has held it in 16 quarters since. The position peaked at $12.8M in Q1 2015. 686 funds tracked by Wall St. Rank hold TEVA as of Q1 2017.

  • Agran Libbie held 162,540 shares of Teva Pharmaceuticals worth $5.22M as of Q1 2017.
  • Agran Libbie sold 7,765 Teva Pharmaceuticals shares in Q1 2017, an estimated $265K.
  • Teva Pharmaceuticals made up 1.23% of Agran Libbie's portfolio in Q1 2017, its #34 holding.
  • Agran Libbie first reported a position in Teva Pharmaceuticals in Q2 2013 and has held it in 16 quarters since.
  • Agran Libbie's Teva Pharmaceuticals position peaked at $12.8M in Q1 2015.
  • 686 funds tracked by Wall St. Rank held Teva Pharmaceuticals as of Q1 2017.

Based on Agran Libbie's 13F filing for Q1 2017, filed 27 Apr 2017.